Back

Impact of high-power and very high-power short-duration radiofrequency ablation on procedure characteristics and first-pass isolation during pulmonary vein isolation

26 August 2022 (08:00 - 19:30)
Organised by:
Congress Presentation Part of: Novel insights in atrial fibrillation ablation procedures Rhythm Control, Catheter Ablation ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Doctor Zoltan Sallo

Semmelweis University Heart and Vascular Center, Budapest (Hungary)

4 More presentations in this session

Presentation thumbnail
Cryoballoon ablation of atrial fibrillation in octogenarians: one year results from the Cryo Global Registry
Doctor D. Lawin (Bielefeld, DE)
Abstract Slides Video
Presentation thumbnail
Atrial tattoos lines: a new method to terminate atrial fibrillation
Professor C. Schmidt (Goettingen, DE)
Abstract Slides Video
Presentation thumbnail
Effect of the epicardial fat volume on the outcomes after a left atrial posterior wall isolation in addition to pulmonary vein isolation in patients with persistent atrial fibrillation
Doctor D. Kim (Seoul, KR)
Abstract Slides Video
Presentation thumbnail
Atrioventricular nodal ablation with pacemaker implant is associated with improved safety outcomes compared to pulmonary vein isolation of atrial fibrillation with heart failure
Doctor N. Olarte (Miami, US)
Abstract Slides Video

Access the full session

Session thumbnail
Novel insights in atrial fibrillation ablation procedures

The Event

Event poster

ESC Congress 2022

26 August - 29 August 2022
You may be interested in
thumbnail
Congress Presentation
High power short duration and very high power short duration protocol: a comparison between two effective strategies of atrial fibrillation transcatheter ablation with radiofrequency
thumbnail
Congress Presentation
Lesion metrics analysis of very high-power vs. high-power short duration radiofrequency ablation in a porcine ex vivo model.
thumbnail
Congress Presentation
Feasibility of very high-power, short-duration ablation with the QDOT Micro catheter: initial findings from the Q-POWER Study

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources